Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Income: 2020-2025

Historic Non Operating Income for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$365,000.

  • Biofrontera's Non Operating Income rose 48.30% to -$365,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $27,000, marking a year-over-year decrease of 99.59%. This contributed to the annual value of -$527,000 for FY2024, which is 120.59% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Non Operating Income is -$365,000, which was down 38.26% from -$264,000 recorded in Q2 2025.
  • Biofrontera's 5-year Non Operating Income high stood at $8.7 million for Q1 2022, and its period low was -$12.9 million during Q4 2021.
  • In the last 3 years, Biofrontera's Non Operating Income had a median value of -$365,000 in 2025 and averaged $158,636.
  • As far as peak fluctuations go, Biofrontera's Non Operating Income spiked by 10,913.92% in 2022, and later tumbled by 260.24% in 2023.
  • Over the past 5 years, Biofrontera's Non Operating Income (Quarterly) stood at -$12.9 million in 2021, then spiked by 122.03% to $2.8 million in 2022, then soared by 160.40% to $7.4 million in 2023, then slumped by 95.76% to $313,000 in 2024, then soared by 48.30% to -$365,000 in 2025.
  • Its Non Operating Income stands at -$365,000 for Q3 2025, versus -$264,000 for Q2 2025 and $343,000 for Q1 2025.